Benjamin Resio, MD
Assistant ProfessorAbout
Research
Publications
2026
Real-World Outcomes of Induction Chemoimmunotherapy in Patients with Non-Small Cell Lung Cancer Who Have Never Smoked
Baskin A, Canavan M, Resio B, Boffa D, Caturegli G. Real-World Outcomes of Induction Chemoimmunotherapy in Patients with Non-Small Cell Lung Cancer Who Have Never Smoked. JTCVS Open 2026, 101983. DOI: 10.1016/j.xjon.2026.101983.Peer-Reviewed Original ResearchIs Pneumonectomy Appropriate after Chemoimmunotherapy? Outcomes of Neoadjuvant Chemoimmunotherapy followed by Pneumonectomy in the United States
Caturegli G, Jernigan E, Canavan M, Lynch A, Kramer R, Patil J, Esnaola G, Boffa D, Resio B. Is Pneumonectomy Appropriate after Chemoimmunotherapy? Outcomes of Neoadjuvant Chemoimmunotherapy followed by Pneumonectomy in the United States. JTCVS Open 2026, 102048. DOI: 10.1016/j.xjon.2026.102048.Peer-Reviewed Original ResearchIs Pneumonectomy Appropriate after Chemoimmunotherapy? Outcomes of Neoadjuvant Chemoimmunotherapy followed by Pneumonectomy in the United States
Caturegli G, Jernigan E, Canavan M, Lynch A, Kramer R, Patil J, Esnaola G, Boffa D, Resio B. Is Pneumonectomy Appropriate after Chemoimmunotherapy? Outcomes of Neoadjuvant Chemoimmunotherapy followed by Pneumonectomy in the United States. JTCVS Open 2026, 102047. DOI: 10.1016/j.xjon.2026.102047.Peer-Reviewed Original ResearchTreatment and Prognosis of Thymic Neuroendocrine Neoplasms in the United States
Caturegli G, Patil J, Lynch A, Canavan M, Jernigan E, Esnaola G, Boffa D, Resio B. Treatment and Prognosis of Thymic Neuroendocrine Neoplasms in the United States. Annals Of Thoracic Surgery Short Reports 2026 DOI: 10.1016/j.atssr.2026.06.035.Peer-Reviewed Original ResearchRadiographic tumor regression as a predictor for pathologic response after neoadjuvant therapy for non–small cell lung cancer
Bader J, Ermer T, de Santis W, Ragoowansi H, Kramer R, Tremblay E, Resio B, Boffa D, Blasberg J, Bader A, Dacic S, Woodard G. Radiographic tumor regression as a predictor for pathologic response after neoadjuvant therapy for non–small cell lung cancer. JTCVS Open 2026, 32: 101831. PMID: 42604290, PMCID: PMC13477020, DOI: 10.1016/j.xjon.2026.101831.Peer-Reviewed Original ResearchReal-World Outcomes of Radiation After Chemoimmunotherapy for Stage III Lung Cancer
Caturegli G, Canavan M, Ayoade O, Boffa D, Resio B. Real-World Outcomes of Radiation After Chemoimmunotherapy for Stage III Lung Cancer. Clinical Lung Cancer 2026, 27: 48-54.e2. PMID: 42070908, DOI: 10.1016/j.cllc.2026.03.016.Peer-Reviewed Original ResearchUse of Complementary and Alternative Medicine in the Management of Breast Cancer
Ayoade O, Caturegli G, Canavan M, Resio B, Berger E, Boffa D. Use of Complementary and Alternative Medicine in the Management of Breast Cancer. JAMA Network Open 2026, 9: e260337. PMID: 41770560, PMCID: PMC12954545, DOI: 10.1001/jamanetworkopen.2026.0337.Peer-Reviewed Original Research
2025
Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non–small cell lung cancer
Caturegli G, Kaminski M, Canavan M, Ayoade O, Resio B, Boffa D. Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non–small cell lung cancer. JTCVS Open 2025, 28: 554-564. PMID: 41473080, PMCID: PMC12745116, DOI: 10.1016/j.xjon.2025.09.016.Peer-Reviewed Original ResearchMortality Risk and Cause of Death Associated With Removal of the Adult Thymus: Analysis of the U.S. Thymoma Population
Resio B, Canavan M, Caturegli G, Detterbeck F, Boffa D. Mortality Risk and Cause of Death Associated With Removal of the Adult Thymus: Analysis of the U.S. Thymoma Population. Journal Of Thoracic Oncology 2025, 21: 186-194. PMID: 40865907, DOI: 10.1016/j.jtho.2025.08.017.Peer-Reviewed Original ResearchProlonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis
Zhan P, Canavan M, Bader J, Boffa D, Resio B, Woodard G. Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis. The Annals Of Thoracic Surgery 2025, 121: 633-642. PMID: 40588180, DOI: 10.1016/j.athoracsur.2025.06.015.Peer-Reviewed Original Research
Clinical Care
Overview
Benjamin Resio, MD, is a thoracic surgeon who treats the entire spectrum of thoracic surgical diseases. He has a special interest in thoracic surgical oncology, multidisciplinary care for lung and esophageal cancer, and minimally invasive and robotic surgery. Dr. Resio cares for patients as part of the Center for Thoracic Cancers at Smilow Cancer Hospital.
Also an assistant professor of surgery at Yale School of Medicine, Dr. Resio received his medical degree with honors from Dartmouth Medical School, where he was elected to the Alpha Omega Alpha honor society. He completed his residency at Yale School of Medicine, followed by a fellowship in cardiothoracic surgery at Memorial Sloan Kettering Cancer Center.
Clinical Specialties
Thoracic Surgery
Yale Medicine News
News
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.